AbbVie
ABBV
#26
Rank
โ‚ฌ336.08 B
Marketcap
190,16ย โ‚ฌ
Share price
-0.29%
Change (1 day)
18.54%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

Earnings for AbbVie (ABBV)

Earnings in 2025 (TTM): โ‚ฌ1.28 Billion

According to AbbVie's latest financial reports the company's current earnings are โ‚ฌ59.64 Billion. In 2024 the company made an earning of โ‚ฌ3.16 Billion a decrease over its 2023 earnings that were of โ‚ฌ5.32 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AbbVie from 2011 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) โ‚ฌ1.28 B-59.5%
2024 โ‚ฌ3.16 B-40.54%
2023 โ‚ฌ5.32 B-53.62%
2022 โ‚ฌ11.47 B3.76%
2021 โ‚ฌ11.06 B282.25%
2020 โ‚ฌ2.89 B-59.67%
2019 โ‚ฌ7.17 B62.13%
2018 โ‚ฌ4.42 B-32.74%
2017 โ‚ฌ6.57 B-1.99%
2016 โ‚ฌ6.71 B18.65%
2015 โ‚ฌ5.65 B180.5%
2014 โ‚ฌ2.01 B-55.57%
2013 โ‚ฌ4.54 B-6.86%
2012 โ‚ฌ4.87 B56.05%
2011 โ‚ฌ3.12 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚ฌ10.09 B 613.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ6.84 B 383.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ19.16 B 1,255.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ7.01 B 396.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚ฌ8.41 B 495.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚ฌ1.62 B 14.70%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚ฌ7.93 B 461.62%๐Ÿ‡ฌ๐Ÿ‡ง UK
AstraZeneca
AZN
โ‚ฌ11.14 B 688.55%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
โ‚ฌ0.49 B-64.87%๐Ÿ‡บ๐Ÿ‡ธ USA